XML 40 R28.htm IDEA: XBRL DOCUMENT v3.19.1
Equity (Tables)
6 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Schedule of Stock Options Activity
The following table summarizes stock option activity under the Equity Plans for the six months ended March 31, 2019:


Number of Shares
 
Weighted Average Exercise Price
 
Weighted Average
Remaining Contractual Life
(in years)
 
Aggregate Intrinsic Value (*) (in thousands)
Outstanding as of September 30, 2018
69,980

 
$4.74
 
 
 
 
Granted

 

 
 
 
 
Exercised
(208
)
 
$3.97
 
 
 

Forfeited
(52
)
 
$3.97
 
 
 
 
Expired
(1,267
)
 
$5.21
 
 
 
 
Outstanding as of March 31, 2019
68,453

 
$4.74
 
4.70
 
$
1

Exercisable as of March 31, 2019
48,118

 
$4.76
 
3.87
 
$
1

Vested and expected to vest as of March 31, 2019
68,453

 
$4.74
 
4.70
 
$
1


(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option's exercise price and the underlying stock price. For the six months ended March 31, 2018, the intrinsic value of options exercised was $13,000.
Schedule of Restricted Stock Activity
The following table summarizes the activity related to RSUs and RSAs subject to time-based vesting requirements for the six months ended March 31, 2019:

Restricted Stock Activity
 
Restricted Stock Units
 
Restricted Stock Awards
 
Number of Shares
 
Weighted Average Grant Date Fair Value
 
Number of Shares
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
1,011,621

 
$6.04
 
8,154

 
$8.20
Granted
 
63,254

 
$3.94
 

 
$0.00
Vested
 
(223,174
)
 
$6.00
 

 
$0.00
Forfeited
 
(117,108
)
 
$4.73
 

 
$0.00
Non-vested as of March 31, 2019
 
734,593

 
$6.08
 
8,154

 
$8.20
Schedule of Performance Share Activity
The following table summarizes the activity related to PSUs and PRSAs for the six months ended March 31, 2019:

Performance Stock Activity
 
Performance Stock Units
 
Performance Stock Awards
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
 
Number of Shares (at Target)
 
Weighted Average Grant Date Fair Value
Non-vested as of September 30, 2018
 
397,777

 
$8.48
 
33,333

 
$12.25
Granted
 

 
$0.00
 

 
$0.00
Vested
 
(30,874
)
 
$7.14
 

 
$0.00
Forfeited
 
(132,579
)
 
$7.24
 

 
$0.00
Non-vested as of March 31, 2019
 
234,324

 
$9.35
 
33,333

 
$12.25
Schedule of Stock-based Compensation Expense - By Award Type
The effect of recording stock-based compensation expense was as follows:

Stock-based Compensation Expense - by award type
For the three months ended March 31,
 
For the six months ended March 31,
(in thousands)
2019
 
2018
 
2019
 
2018
Employee stock options
$
7

 
$
10

 
$
14

 
$
20

Restricted stock units and awards
396

 
412

 
782

 
863

Performance stock units and awards
229

 
361

 
169

 
650

Employee stock purchase plan
42

 
75

 
82

 
161

Outside director equity awards and fees in common stock
47

 
75

 
99

 
154

Total stock-based compensation expense
$
721

 
$
933

 
$
1,146

 
$
1,848

Schedule of Stock-based Compensation Expense - By Expense Type
Stock-based Compensation Expense - by expense type
For the three months ended March 31,
For the six months ended March 31,
(in thousands)
2019
 
2018
2019
 
2018
Cost of revenue
$
109

 
$
115

$
220

 
$
254

Selling, general, and administrative
473

 
652

632

 
1,290

Research and development
139

 
166

294

 
304

Total stock-based compensation expense
$
721

 
$
933

$
1,146

 
$
1,848

Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the computation of basic and diluted net loss per share:

Basic and Diluted Net Loss Per Share
 
For the three months ended March 31,
 
For the six months Ended March 31,
(in thousands, except per share)
 
2019
 
2018
 
2019
 
2018
Numerator:
 
 
 
 
 
 
 
 
   Loss from continuing operations
 
$
(4,994
)
 
$
(3,071
)
 
$
(10,532
)
 
$
(3,153
)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share
 
(4,994
)
 
(3,071
)
 
(10,532
)
 
(3,153
)
Denominator:
 
 
 
 
 
 
 
 
Denominator for basic and fully diluted net loss per share - weighted average shares outstanding
 
27,652

 
27,197

 
27,592

 
27,113

 
 
 
 
 
 
 
 
 
Net loss per basic and fully diluted share
 
$
(0.18
)
 
$
(0.11
)
 
$
(0.38
)
 
$
(0.12
)
 
 
 
 
 
 
 
 
 
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation
 
849

 
972

 
535

 
793

 
 
 
 
 
 
 
 
 
Average market price of common stock
 
$
4.26

 
$
6.05

 
$
4.48

 
$
6.79

Schedule of Common Stock Reserved for Future Issuances
As of March 31, 2019, we had common stock reserved for the following future issuances:
Future Issuances
Number of Common Stock Shares Available for Future Issuances
Exercise of outstanding stock options
68,453

Unvested restricted stock units and awards
742,747

Unvested performance stock units and awards (at 200% maximum payout)
535,314

Purchases under the employee stock purchase plan
674,152

Issuance of stock-based awards under the Equity Plans
3,621,906

Purchases under the officer and director share purchase plan
88,741

Total reserved
5,731,313